In Episode 30 of the Thoroughly Thriving Podcast, Darren and Sean sit down with Junior Laysa, VP and Head of Operations at Nkarta, Inc, to explore what truly drives high-performing teams in biotech.

Junior shares real-world leadership insights from scaling operations in complex, highly regulated environments where cross-functional alignment isn’t optional — it’s essential for survival.

From building intentional culture to creating psychological safety for innovation, Junior reveals the leadership practices that transform average teams into exceptional ones.

In this episode, we discuss:

• Why culture is the foundation of operational excellence
• How leaders build connection and trust across teams
• The importance of psychological safety in innovation
• Breaking down silos across R&D, manufacturing, and quality
• Practical strategies for developing future leaders
• The cultural signals that reveal whether a team is thriving

If you lead teams in biotech, pharma, life sciences, or any high-stakes industry, this conversation offers powerful leadership lessons.

👉 Subscribe for more leadership insights from biotech and life sciences leaders.

👉 Share this episode with someone building teams in complex environments.

(00:00) Welcome to Thoroughly Thriving

(00:46) Meet Junior Laysa

(02:04) The Importance of Leadership in Operations

(03:49) Building Culture While Scaling Teams

(06:13) Leading Through Organizational Change

(09:15) Developing Future Leaders

(13:13) Culture and Innovation in Biotech

(17:09) Breaking Down Organizational Silos

(21:12) Collaboration and Team Connection

(23:26) Measuring Healthy Team Culture

(27:09) Leadership Takeaways and Closing Thoughts

In Episode 29 of the Thoroughly Thriving Podcast, we sit down with Jerlyn to unpack one of the most overlooked leadership challenges — avoiding conflict.

Jerlyn shares powerful insights on why unaddressed tension quietly grows, how it impacts teams and performance, and what it actually takes to lead through discomfort with clarity and confidence.

If you’re in leadership, building a team, or navigating high-stakes environments, this conversation will challenge how you think about communication, accountability, and growth.

In this episode, we cover:

• Why avoiding conflict creates bigger problems later
• How tension builds beneath the surface in teams
• The mindset shift required for effective leadership
• Practical ways to approach difficult conversations
• How strong leaders create clarity instead of comfort

👉 If this episode challenges you, share it with someone in leadership.

👉 Subscribe for more conversations with top leaders in biotech, pharma, and beyond.

(00:00) Introduction to Jerlyn

(02:15) Why leaders avoid conflict

(06:40) The hidden cost of unaddressed tension

(12:05) How conflict impacts team performance

(18:30) Shifting your mindset around hard conversations

(25:10) Practical ways to address tension early

(31:45) Building a culture of clarity

(38:20) Leadership growth through discomfort

(44:10) Final thoughts and key takeaways

In Episode 28 of Thoroughly Thriving, we sit down with Abby Kennedy, Vice President of Clinical Operations at Jasper Therapeutics, to explore what leadership truly looks like inside today’s evolving biotech landscape.

With over 20 years of experience in pharmaceutical and biotech organizations, Abby shares practical wisdom on:

• Navigating difficult workplace dynamics
• Leading with curiosity instead of frustration
• Resetting toxic team patterns
• Integrating contractors effectively into core teams
• Scaling small biotech organizations strategically

This episode dives deep into the human side of clinical operations — from conflict resolution to building high-performance teams in unpredictable development phases.

If you’re a clinical leader, biotech executive, or emerging manager looking to strengthen your leadership approach in 2026 and beyond, this conversation is packed with real-world insights you can apply immediately.

Resource:

• Getting Along: How to Work with Anyone (Even Difficult People) by Amy Gallo

👉 Don’t forget to like, subscribe, and share with your network.

#ClinicalOperations #BiotechLeadership #DrugDevelopment #PharmaCareers #ThoroughlyThriving #LifeSciencesLeadership

00:00 – Welcome to Thoroughly Thriving02:07 – Abby Kennedy Introduction04:00 – First Podcast Experience05:17 – Handling Challenging Colleagues07:36 – Taking the High Road in Leadership10:54 – Curiosity vs. Frustration in Management12:55 – Resetting Toxic Team Dynamics14:50 – Working Agreements That Actually Work16:38 – Build vs. Buy: Scaling Clinical Teams18:43 – Contractor Models Explained20:41 – Integrating Contractors Into Core Teams22:22 – Creating Inclusive Culture for Contractors24:21 – Why Contractors Follow Great Leaders26:34 – Final Leadership Reflections

In this episode of Thoroughly Thriving, hosts Sean Burroughs and Darren Thevathasan sit down with Jonathon Parker, a seasoned neuroscience and regulatory leader with experience across Big Pharma and innovative biotech.

Jonathon shares how human-centered leadership, curiosity, and patient-first thinking shape better regulatory strategies—especially in an era driven by AI, digital biomarkers, and precision medicine. From navigating neuroscience complexity to mentoring the next generation of biotech leaders, this conversation explores what it really takes to move science forward.

Key Takeaways:

• Why leadership psychology matters in drug development
• How AI and digital biomarkers are transforming neuroscience
• Keeping patients at the center in data-heavy environments
• Career advice for emerging biotech and clinical leaders
• Why the next decade may be a new golden age for neuroscience

👉 Subscribe for more conversations at the intersection of leadership, innovation, and life sciences.

👉 Connect with us if you’re a professional looking to collaborate or partner.

(00:00) Jonathon Parker’s Background

(01:25) Leadership Across Global Pharma Cultures

(03:45) AI & Digital Biomarkers in Neuroscience

(06:45) Keeping Patients at the Center

(09:20) Motivation in Rare Disease

(10:25) Career Advice for Biotech Leaders

(14:20) The Future of Neuroscience Innovation

(16:45) A New Golden Age Ahead

In this episode of Thoroughly Thriving, hosts Darren Thevathasan and Sean Burroughs sit down with Joseph Kim, Chief Strategy Officer at ProofPilot, to break down what’s really slowing down clinical research — and how the industry can get back to the fundamentals that actually work.

Joseph shares insights on:

• Why clinical research has drifted away from foundational scientific principles
• The true cost and complexity behind patient recruitment
• How variability across trial sites destroys data quality
• What AI and automation can—and cannot—fix in clinical trials
• Why consistency, simplicity, and operational clarity outperform innovation fads- How ProofPilot is reshaping trial execution through workflow automation

If you work in clinical operations, research strategy, biotech leadership, patient recruitment, or digital health, this conversation offers rare clarity on where trials break… and where the future is headed.

👉 Listen, learn, and share with someone leading clinical research.

#clinicaltrials #proofpilot #drugdevelopment #clinicaloperations #biotechleadership #researchinnovation #aiinhealthcare

00:00 – Introduction

01:22 – Who is Joseph Kim?

03:10 – Getting back to basics in clinical research

06:45 – The real cost of patient recruitment

10:32 – Variability: the silent trial killer

14:18 – What AI can—and can’t—fix

18:42 – Protocol design mistakes

22:55 – Workflow vs. technology

28:01 – ProofPilot’s approach

33:27 – Industry misconceptions

38:10 – Final insights + wrap up

In this episode of Thoroughly Thriving, hosts Darren Thevathasan and Sean Burroughs sit down with Dr. Cameron Trenor, Chief Medical Officer at Cellarity and pediatric hematologist oncologist at Boston Children’s Hospital.

Cameron shares his journey from academic medicine to biotech leadership, including:

• Building medical leadership functions from the ground up
• Why evidence-based decision-making matters in drug development
• Balancing the roles of specialist and generalist in leadership
• Building high-performing teams in biotech
• How staying connected to patient care shapes his leadership

👉 Whether you’re in biotech, pharma, or healthcare leadership, this episode is packed with insights on team-building, culture, and evidence-driven innovation.

🔗 Listen now and discover how leaders like Cameron are shaping the future of medicine.

#BiotechLeadership #DrugDevelopment #EvidenceBasedMedicine #ThoroughlyThrivingPodcast

In this episode of Thoroughly Thriving, hosts Darren Thevathasan and Sean Burroughs sit down with Dr. Gavin Corcoran, Chief Development Officer at Formation Bio—a trailblazing AI-native pharma company. Gavin shares insights from a remarkable career in global pharma and biotech, offering practical wisdom on leadership in high-pressure environments, decision-making with incomplete data, and how authenticity creates resilient, high-trust teams.

We dive into:

• How Formation Bio is disrupting traditional R&D models using AI
• The importance of “stickability” and courage in a career journey
• Why vulnerability is a strength in leadership
• What it really takes to create revolutionary—not just evolutionary—change in biotech

💡 Whether you’re in healthcare, tech, or leading in uncertain times, this episode is packed with actionable takeaways.

👉 Don’t forget to like, subscribe, and share!

📌 Connect with Gavin Corcoran and learn more about Formation Bio at https://www.formation.bio/.

#Leadership #Biotech #AIinPharma #GavinCorcoran #ThoroughlyThriving

In this episode of Thoroughly Thriving, we sit down with Marcus Littman, Vice President of Drug Safety at Iovance Biotherapeutics, to explore his remarkable 20+ year journey through the evolving world of pharmacovigilance.

From serendipitous beginnings to leading global safety teams, Marcus shares:

• How signal detection blends science with storytelling
• The role of AI and automation in shaping drug safety
• Why collaboration is key across clinical and safety teams
• Real talk on career growth, leadership, and finding your “why”
• His vision for redesigning safety systems from the ground up

If you're in biotech, drug development, or healthcare leadership—this episode is a must-listen.

👉 Don’t forget to like, subscribe, and share to keep the conversation growing.

🔗 Connect with us: https://www.iovance.com/

🎧 Listen on Spotify, Apple Podcasts & all major platforms.

#DrugSafety #Pharmacovigilance #BiotechLeadership #SignalDetection #AIinHealthcare #ThoroughlyThriving #MarcusLittman #ThoroughGroup

In this Thoroughly Thriving host-only episode, Darren Thevathasan and Sean Burroughs pull back the curtain on one of the most foundational topics: Living Your Legacy.

They get personal—discussing family, leadership, career, and how intentionality defines the legacy we leave in every area of life.

🎙️ Topics Covered:

• What legacy really means (beyond money or titles)
• How intentionality helps align work, family, and purpose - Practical rhythms for weekly alignment
• Leading with values in life sciences and beyond
• The difference between being seen... and being known
• Why great leaders light fires within

If you're in a season of growth, leadership, or reflection, this episode will inspire and challenge you.

🔔 Subscribe for more leadership, life sciences, and purpose-driven content.

💬 Comment and share your biggest takeaway!

#Leadership #Legacy #PurposeDriven #LifeSciences #Entrepreneurship #ThoroughlyThriving #IntentionalLiving #CoreValues #WorkLifeBalance

Sterling Chung, VP of Regulatory Affairs and Quality at Aurion Biotech, joins Thoroughly Thriving for an incredible deep dive into biotech leadership, regulatory strategy, and the evolution of innovation in cell and gene therapy.With over 20 years of experience across Big Pharma and agile biotech startups, Sterling shares what drives him, the importance of mentorship, how he failed forward through an early FDA meeting, and what every CEO should know about regulatory affairs.🎯 Key Takeaways:

• The critical mindset shift from Big Pharma to biotech
• How to lead when you're the only regulatory voice
• Lessons from a failed FDA interaction
• The future of cell & gene therapy
• Why regulatory leaders must drive innovation, not slow it down

💡 Whether you're a biotech founder, clinical exec, or regulatory leader—this episode is packed with insight and inspiration.🎧 Listen now and subscribe for more visionary conversations.#biotech #regulatoryaffairs #podcast #sterlingchung #leadership #celltherapy #genetherapy #innovation #fda #clinicaldevelopment